Loading insider details...
Beta
Latest Form 4 (Sep 30, 2026): Sale of 3,097 DFTX shares, $113.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 3,097 | $113.3K |
| Sep 14, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 125,000 | n/a |
| Aug 12, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 62,500 | n/a |
| Jun 26, 2026 | Definium Therapeutics, Inc. (DFTX) | Sale | 2,867 | $129.1K |
| Jun 22, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 62,500 | n/a |
| Feb 5, 2026 | Definium Therapeutics, Inc. (DFTX) | Grant/Award | 115,000 | n/a |
| Apr 1, 2025 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 1,875 | n/a |
| Mar 18, 2025 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/Award | 350,000 | n/a |
| Oct 4, 2024 | BioXcel Therapeutics, Inc. (BTAI) | Grant/Award | 21,250 | n/a |
| Sep 17, 2024 | BioXcel Therapeutics, Inc. (BTAI) | Exercise/Conversion | 750 | n/a |